Emami Limited · NSE:EMAMILTD
Emami — Q3 FY2019 Earnings Presentation
16 slides from Emami's earnings presentation, Jan 31, 2019
Slide 1: Cover letter to stock exchanges
emami limited emami — The Secretary The National Stock Exchange of India Ltd. Exchange Plaza, Plot No. C/1, G. Block Bandra Kurla Complex, Bandra (E) Mumbai - 400 051 The Secretary The Calcutta Stock Exchange Limited 7, Lyons Range Kolkata - 700 001 Dear Sir, Date: 31st January, 2019 The Secretary B
Slide 2: Q3FY19 Performance Update
ANTI PIMPLE Q3FY19 Performance Update 31st January 2019
Slide 3: Q3 & 9MFY19 Snapshot (Consolidated)
Q3 & 9MFY19 Snapshot (Consolidated) ₹ in Millions Net Sales* EBIDTA PBT (before Exceptional items) Q3FY19 8,004 Q3FY19 2,666 Q3FY19 1,867 Q3FY18 7,437 Q3FY18 2,647 Q3FY18 1,810 Net Sales* EBIDTA PBT (before Exceptional items) 9MFY19 20,235 9MFY19 5,795 9MFY19 3,306 9MFY18 18,965 9MFY18 5,462 9MFY18
Slide 4: Business Performance
Business Performance BUSINESS WISE NET SALES PERFORMANCE 9MFY19 Business Wise 9MFY19 Q3FY19 Sales Split Domestic* CSD 8% 4% IMD 7% 12% IMD 9% 18% Domestic 84% CSD 5% 2% 2 *Note: 9MFY19 Domestic Net Sales is LTL growth (adjusted for GST in Q1)
Slide 5: Navratna and Pain Management
Navratna Navratna grew by 10% during the quarter and by 13% in 9MFY19 Cool Oils Market Share (vol) at 66.1% increased by 340 bps in Q3FY19 Pain Management Pain management range grew by 6% in Q3 and by 7% in 9MFY19. Balms maintained leadership in Q3FY19 with a market Share (vol) at 54.4% A ne
Slide 6: BoroPlus and 7 Oils in One
BoroPlus BoroPlus range grew by 4% in Q3. 9MFY19 sales were flat compared to previous year . Sales were impacted due to delayed winters. Antiseptic cream maintained leadership with a Market Share (vol) of 72.7% in Q3FY19 Brand Positioning of BoroPlus Total Results Moisturising lotion changed
Slide 7: Kesh King and Healthcare range
Kesh King Kesh King range grew by 26% in Q3 and by 12% in 9MFY19. Q3FY19 Market Share (vol) at 29.8% grew by 260 bps Kesh King relaunched in new premium look with comb applicator for targeted oil application. Certified to be 2x more effective than other Ayurvedic Oils Healthcare range Heal
Slide 8: Male Grooming
Male Grooming Male grooming range declined by 2% in Q3. However, it grew by 6% in 9MFY19. Fairness Creams maintained leadership with a Market Share (vol) of 63.7% in Q3FY19 Face wash Market Share (vol) at 15.2% grew by 50 bps in Q3FY19 Launched a new variant, Fair and Handsome 5-In-1 Pimple
Slide 9: International Business
International Business OTHERS Sales grew by 18% in Q3 and grew by 9% in 9MFY19. 4% AFRICA 8% SAARC and MENAP regions performed well during the CIS 12% quarter. IMD SAARC 9MFY19 44% Cluster Wise Market share gains for major brands across key geographies Contribution MENAP 32% SAARC South Asian
Slide 10: Acquisition of Creme 21
Acquisition of Creme 21 Acquired Creme 21, a German brand with strong roots & brand recall on 25th January 2019 The brand offers skin care and body care products such as creams and lotions, shower gels, sun care range, men’s range, etc. Strong presence in Middle East and other focus markets.
Slide 11: Financial Analysis
Financial Analysis Earnings analysis for Q3 & 9MFY19 9
Slide 12: Q3FY19 Financial analysis
Q3FY19 Financial analysis Cost of Goods Sold Staff Costs A&P Spends (as a % of Sales) (as a % of Sales) (₹ in Millions) + 380 bps - 40 bps -120 bps 9.0% 33.0% 1,293 1,291 8.6% 29.2% Q3FY18 Q3FY19 Q3FY18 Q3FY19 Q3FY18 Q3FY19 Admin & Other Exp Other Income Interest Paid (as a % of Sales) (₹ in Million
Slide 13: 9MFY19 Financial analysis
9MFY19 Financial analysis Cost of Goods Sold Staff Costs A&P Spends (as a % of Sales) (as a % of Sales) (₹ in Millions) + 120 bps + 10 bps - 120 bps 10.3% 3,709 3,712 32.7% 31.5% 10.2% 9MFY18 9MFY19 9MFY18 9MFY19 9MFY18 9MFY19 Admin & Other Exp Other Income Interest Paid (as a % of Sales) (₹ in Mill
Slide 14: Q3FY19 Summarized Financials
Q3FY19 Summarized Financials ₹ in Millions Particulars Q3FY19 % Q3FY18 % Growth % FY18 % Net Sales 8,004.4 98.7% 7,437.0 98.3% 7.6% 25,000.1 98.4% Other Operating Income 104.6 1.3% 130.9 1.7% -20.1% 408.2 1.6% Revenue from Operations 8,109.0 100.0% 7,567.9 100.0% 7.1% 25,408.3 100.0% Materials Cost
Slide 15: 9MFY19 Summarized Financials
9MFY19 Summarized Financials ₹ in Millions Particulars 9MFY19 % 9MFY18 % Growth % FY18 % Net Sales 20,235.0 98.5% 18,964.6 98.6% 6.7% 25,000.1 98.4% Other Operating Income 298.0 1.5% 274.0 1.4% 8.8% 408.2 1.6% Revenue from Operations 20,533.0 100.0% 19,238.6 100.0% 6.7% 25,408.3 100.0% Materials Cos
Slide 16: Thank you
Thank you